ACADIA PHARMACEUTICALS INC. Capital Expenditures
ACADIA PHARMACEUTICALS INC. (ACAD) reported Capital Expenditures of $10.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-05
- ACADIA PHARMACEUTICALS INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $5.09M, a 1613.47% increase year-over-year.
- ACADIA PHARMACEUTICALS INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $5.21M.
- ACADIA PHARMACEUTICALS INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $4.00M, a 784.11% increase year-over-year.
- ACADIA PHARMACEUTICALS INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $388.00K, a 454.29% increase year-over-year.
- ACADIA PHARMACEUTICALS INC. payments to acquire property, plant, and equipment for fiscal 2025 was $4.69M, a 796.75% increase from fiscal 2024.
- ACADIA PHARMACEUTICALS INC. payments to acquire property, plant, and equipment for fiscal 2024 was $523.00K, a 946.00% increase from fiscal 2023.
- ACADIA PHARMACEUTICALS INC. payments to acquire property, plant, and equipment for fiscal 2023 was $50.00K.
- ACADIA PHARMACEUTICALS INC. payments to acquire property, plant, and equipment for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $5.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $10.30M 10-Q · filed 2026-08-05 | $14.31M derived: sum of 3 quarters · filed 2026-08-05 | $14.69M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $5.21M 10-Q · filed 2026-05-07 | $9.22M derived: sum of 2 quarters · filed 2026-05-07 | $9.61M derived: sum of 3 quarters · filed 2026-05-07 | $9.90M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.39M derived: sum of 2 quarters · filed 2026-02-26 | $4.69M derived: sum of 3 quarters · filed 2026-08-05 | $4.69M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $388.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $685.00K derived: sum of 2 quarters · filed 2026-08-05 | $685.00K 10-Q · filed 2025-11-06 | $1.14M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $297.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $297.00K 10-Q · filed 2026-08-05 | $750.00K derived: sum of 3 quarters · filed 2026-08-05 | $820.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | $453.00K derived: sum of 2 quarters · filed 2026-05-07 | $523.00K derived: sum of 3 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $453.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $523.00K derived: sum of 2 quarters · filed 2026-02-26 | $523.00K 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $70.00K 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $50.00K 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $50.00K 10-Q · filed 2024-11-07 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $0.00 derived: sum of 2 quarters · filed 2023-11-03 | $0.00 10-Q · filed 2023-11-03 | $1.00K derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $1.00K derived: sum of 3 quarters · filed 2024-02-28 | $1.00K derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | $1.00K derived: sum of 2 quarters · filed 2024-02-28 | $1.00K derived: sum of 3 quarters · filed 2024-02-28 | $46.00K derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.00K derived: sum of 2 quarters · filed 2024-02-28 | $46.00K derived: sum of 3 quarters · filed 2024-02-28 | $1.12M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $45.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.12M 10-Q · filed 2022-11-03 | $3.12M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.12M 10-Q · filed 2022-08-09 | $3.12M derived: sum of 3 quarters · filed 2023-02-28 | $4.84M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $1.08M 10-Q · filed 2022-05-05 | $3.08M derived: sum of 2 quarters · filed 2023-02-28 | $4.80M derived: sum of 3 quarters · filed 2023-02-28 | $7.73M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $3.72M derived: sum of 2 quarters · filed 2023-02-28 | $6.65M derived: sum of 3 quarters · filed 2023-02-28 | $7.59M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $1.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $4.65M derived: sum of 2 quarters · filed 2021-11-09 | $5.59M 10-Q · filed 2021-11-09 | $5.79M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $2.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $3.87M 10-Q · filed 2021-08-05 | $4.07M derived: sum of 3 quarters · filed 2022-03-01 | $4.15M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $934.00K 10-Q · filed 2021-05-06 | $1.14M derived: sum of 2 quarters · filed 2022-03-01 | $1.22M derived: sum of 3 quarters · filed 2022-03-01 | $1.24M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $207.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $287.00K derived: sum of 2 quarters · filed 2022-03-01 | $307.00K derived: sum of 3 quarters · filed 2022-03-01 | $1.13M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $100.00K derived: sum of 2 quarters · filed 2020-11-04 | $922.00K 10-Q · filed 2020-11-04 | $1.45M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $842.00K 10-Q · filed 2020-08-06 | $1.37M derived: sum of 3 quarters · filed 2021-02-25 | $2.38M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | $822.00K 10-Q · filed 2020-05-08 | $1.35M derived: sum of 2 quarters · filed 2021-02-25 | $2.36M derived: sum of 3 quarters · filed 2021-02-25 | $2.48M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | $526.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.54M derived: sum of 2 quarters · filed 2021-02-25 | $1.66M derived: sum of 3 quarters · filed 2021-02-25 | $2.10M 10-K · filed 2021-02-25 | $2.15M 10-K · filed 2019-02-27 |
| 2018-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $1.13M derived: sum of 2 quarters · filed 2019-10-31 | $1.58M 10-Q · filed 2019-10-31 | $1.58M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | $115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $563.00K 10-Q · filed 2019-08-01 | $570.00K derived: sum of 3 quarters · filed 2020-02-27 | $626.00K derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | $448.00K 10-Q · filed 2019-05-02 | $455.00K derived: sum of 2 quarters · filed 2020-02-27 | $511.00K derived: sum of 3 quarters · filed 2020-02-27 | $775.00K derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $63.00K derived: sum of 2 quarters · filed 2020-02-27 | $327.00K derived: sum of 3 quarters · filed 2020-02-27 | $812.00K 10-K · filed 2020-02-27 | |
| 2017-09-30 | $56.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $320.00K derived: sum of 2 quarters · filed 2018-11-06 | $805.00K 10-Q · filed 2018-11-06 | $1.05M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-06-30 | $264.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $749.00K 10-Q · filed 2018-08-08 | $998.00K derived: sum of 3 quarters · filed 2019-02-27 | $1.47M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-03-31 | $485.00K 10-Q · filed 2018-05-04 | $734.00K derived: sum of 2 quarters · filed 2019-02-27 | $1.20M derived: sum of 3 quarters · filed 2019-02-27 | $1.78M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2016-12-31 | $249.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $719.00K derived: sum of 2 quarters · filed 2019-02-27 | $1.30M derived: sum of 3 quarters · filed 2019-02-27 | $1.51M 10-K · filed 2019-02-27 | |
| 2016-09-30 | $470.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.05M derived: sum of 2 quarters · filed 2017-11-07 | $1.26M 10-Q · filed 2017-11-07 | $1.55M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-06-30 | $580.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $787.00K 10-Q · filed 2017-08-08 | $1.08M derived: sum of 3 quarters · filed 2018-02-27 | $1.27M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2016-03-31 | $207.00K 10-Q · filed 2017-05-09 | $500.00K derived: sum of 2 quarters · filed 2018-02-27 | $686.00K derived: sum of 3 quarters · filed 2018-02-27 | $1.36M derived: sum of 4 quarters · filed 2018-02-27 | |
| 2015-12-31 | $293.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $479.00K derived: sum of 2 quarters · filed 2018-02-27 | $1.15M derived: sum of 3 quarters · filed 2018-02-27 | $2.14M 10-K · filed 2018-02-27 | |
| 2015-09-30 | $186.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $860.00K derived: sum of 2 quarters · filed 2016-11-07 | $1.85M 10-Q · filed 2016-11-07 | $1.94M derived: sum of 4 quarters · filed 2017-02-28 | |
| 2015-06-30 | $674.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $1.66M 10-Q · filed 2016-08-04 | $1.76M derived: sum of 3 quarters · filed 2017-02-28 | $1.84M derived: sum of 4 quarters · filed 2017-02-28 | |
| 2015-03-31 | $988.00K 10-Q · filed 2016-05-05 | $1.08M derived: sum of 2 quarters · filed 2017-02-28 | $1.16M derived: sum of 3 quarters · filed 2017-02-28 | $1.16M derived: sum of 4 quarters · filed 2017-02-28 | |
| 2014-12-31 | $94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $174.00K derived: sum of 2 quarters · filed 2017-02-28 | $174.00K derived: sum of 3 quarters · filed 2017-02-28 | $180.00K 10-K · filed 2017-02-28 | |
| 2014-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $80.00K derived: sum of 2 quarters · filed 2015-11-05 | $86.00K 10-Q · filed 2015-11-05 | $214.00K derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $6.00K 10-Q · filed 2015-08-06 | $134.00K derived: sum of 3 quarters · filed 2016-02-29 | $550.00K derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | $6.00K 10-Q · filed 2015-05-07 | $134.00K derived: sum of 2 quarters · filed 2016-02-29 | $550.00K derived: sum of 3 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $544.00K derived: sum of 2 quarters · filed 2016-02-29 | $618.00K 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $416.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $490.00K 10-Q · filed 2014-11-10 | |||
| 2013-06-30 | $74.00K 10-Q · filed 2014-08-05 | ||||
| 2011-12-31 | $3.00K 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |